Literature DB >> 8380428

Regulation of HIV-1 expression by cytokine networks in a CD4+ model of chronic infection.

S T Butera1, B D Roberts, T M Folks.   

Abstract

Using the CD4+ model of chronic HIV-1 infection, OM-10.1, we investigated the influence of TNF-alpha regulatory networks on induced viral expression. Previously, OM-10.1 cultures were characterized to respond to exogenous TNF-alpha, as nearly 100% of the cells were activated to express HIV-1 within 24 h. In this study, OM-10.1 cells were pulse-treated, by applying exogenous factors for short periods of time and then washing, to determine if autocrine TNF-alpha could sustain HIV-1 activation in the absence of additional exogenous stimulation. After a TNF-alpha pulse treatment, the progressive increase of HIV-1-expressing OM-10.1 cells was prevented by the continuous presence of anti-TNF-alpha mAb. The inductive activity of supernatant from TNF-alpha pulse-treated OM-10.1 cultures was completely removed by absorption on immobilized anti-TNF-alpha mAb. In addition, TNF-alpha pulse-treated OM-10.1 cells activated HIV-1 expression in untreated OM-10.1 cells when cultured across a permeable membrane indicating paracrine effects. Interestingly, if TNF-alpha pulse-treated OM-10.1 cells were further pulse-treated with anti-TNF-alpha mAb, a marked reduction in autocrine TNF-alpha was observed although the level of newly synthesized TNF-alpha mRNA remained unaffected. A similar degree of inhibition over autocrine TNF-alpha production was observed when soluble TNF receptors were used as the second pulse treatment in these experiments. Although the applicability of these results to in vivo chronically HIV-1-infected cells remains to be realized, these results do indicate that activated HIV-1 expression can be influenced by self-perpetuating mechanisms during periods of limited exogenous stimulation. Furthermore, physiologic mechanisms involving soluble cytokine receptors that counteract autocrine and paracrine activation of HIV-1 expression are shown here to play a regulatory role.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8380428

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

1.  Selective amplification of RNA utilizing the nucleotide analog dITP and Thermus thermophilus DNA polymerase.

Authors:  T Auer; J J Sninsky; D H Gelfand; T W Myers
Journal:  Nucleic Acids Res       Date:  1996-12-15       Impact factor: 16.971

2.  Correlation of immune activation during late pregnancy and early postpartum with increases in plasma HIV RNA, CD4/CD8 T cells, and serum activation markers.

Authors:  Hong-Ha M Truong; Myung S Sim; Maryanne Dillon; Christel H Uittenbogaart; Ruth Dickover; Susan F Plaeger; Yvonne J Bryson
Journal:  Clin Vaccine Immunol       Date:  2010-10-27

3.  Attenuated Listeria monocytogenes vectors overcome suppressive plasma factors during HIV infection to stimulate myeloid dendritic cells to promote adaptive immunity and reactivation of latent virus.

Authors:  Elizabeth A Miller; Meredith R Spadaccia; Thomas Norton; Morgan Demmler; Ramya Gopal; Meagan O'Brien; Nathaniel Landau; Thomas W Dubensky; Peter Lauer; Dirk G Brockstedt; Nina Bhardwaj
Journal:  AIDS Res Hum Retroviruses       Date:  2015-01       Impact factor: 2.205

4.  Trichomonas vaginalis-induced epithelial monolayer disruption and human immunodeficiency virus type 1 (HIV-1) replication: implications for the sexual transmission of HIV-1.

Authors:  Patricia C Guenthner; W Evan Secor; Charlene S Dezzutti
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

5.  Dimethyl fumarate, an immune modulator and inducer of the antioxidant response, suppresses HIV replication and macrophage-mediated neurotoxicity: a novel candidate for HIV neuroprotection.

Authors:  Stephanie A Cross; Denise R Cook; Anthony W S Chi; Patricia J Vance; Lorraine L Kolson; Bethany J Wong; Kelly L Jordan-Sciutto; Dennis L Kolson
Journal:  J Immunol       Date:  2011-10-05       Impact factor: 5.422

Review 6.  Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infection.

Authors:  S D Lawn; S T Butera; T M Folks
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

7.  Interleukin 1 induces HIV-1 expression in chronically infected U1 cells: blockade by interleukin 1 receptor antagonist and tumor necrosis factor binding protein type 1.

Authors:  E V Granowitz; B M Saget; M Z Wang; C A Dinarello; P R Skolnik
Journal:  Mol Med       Date:  1995-09       Impact factor: 6.354

8.  Rapid culture and quantitation of human immunodeficiency virus type 1 from patient cells without the use of mitogen-stimulated donor cells.

Authors:  P K Kim; S He; J L HO
Journal:  Clin Diagn Lab Immunol       Date:  1994-11

9.  Human immunodeficiency virus type 1 RNA expression by four chronically infected cell lines indicates multiple mechanisms of latency.

Authors:  S T Butera; B D Roberts; L Lam; T Hodge; T M Folks
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

10.  Detection of CD4+ T cells harboring human immunodeficiency virus type 1 DNA by flow cytometry using simultaneous immunophenotyping and PCR-driven in situ hybridization: evidence of epitope masking of the CD4 cell surface molecule in vivo.

Authors:  B K Patterson; C Goolsby; V Hodara; K L Lohman; S M Wolinsky
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.